Literature DB >> 11445164

Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.

P Giakkoupi1, A M Hujer, V Miriagou, E Tzelepi, R A Bonomo, L S Tzouvelekis.   

Abstract

Non-naturally occurring mutants of TEM-17 (E104K), TEM-12 (R164S) and TEM-26 (E104K:R164S) extended-spectrum (ES) beta-lactamases bearing threonine at position 237 were constructed by site-specific mutagenesis and expressed under isogenic conditions in Escherichia coli. Quantification of beta-lactamase activities and immunoblotting indicated that Ala-237-->Thr did not significantly affect expression levels of these ES enzymes. Minimum inhibitory concentrations of beta-lactam antibiotics showed that the presence of threonine at position 237 exerted a dominant effect increasing the enzymes' preference for various early generation cephalosporins over penicillins. Activity against broad-spectrum oxyimino-beta-lactams was also changed. The effect of Ala-237-->Thr on the activity against ceftazidime, aztreonam, cefepime and cefpirome of all three ES TEM enzymes was detrimental. Introduction of Thr-237 improved activity against cefotaxime and ceftriaxone in TEM-12 and TEM-26, but not in TEM-17.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445164     DOI: 10.1111/j.1574-6968.2001.tb10729.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.

Authors:  Séverine Bontron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

2.  Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.

Authors:  Fahd K Majiduddin; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Jocelyne Caillon; Melissa D Barnes; Gilles Potel; Saralee Bajaksouzian; Joseph D Rutter; Amokrane Reghal; Stuart Shapiro; Magdalena A Taracila; Michael R Jacobs; Robert A Bonomo; Cédric Jacqueline
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Authors:  Andrea M Hujer; Malcolm G P Page; Marion S Helfand; Bethany Yeiser; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Magdalena Taracila; John M Hornick; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

6.  Class A carbapenemase FPH-1 from Francisella philomiragia.

Authors:  Marta Toth; Viktoria Vakulenko; Nuno T Antunes; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

7.  Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Authors:  Krisztina M Papp-Wallace; Saralee Bajaksouzian; Ayman M Abdelhamed; Altreisha N Foster; Marisa L Winkler; Julian A Gatta; Wright W Nichols; Raymond Testa; Robert A Bonomo; Michael R Jacobs
Journal:  Diagn Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 2.803

8.  Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.

Authors:  Sebastian G Kurz; Kerstin A Wolff; Saugata Hazra; Christopher R Bethel; Andrea M Hujer; Kerri M Smith; Yan Xu; Lee W Tremblay; John S Blanchard; Liem Nguyen; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

9.  Covalent docking and molecular dynamics simulations reveal the specificity-shifting mutations Ala237Arg and Ala237Lys in TEM beta-lactamase.

Authors:  Gabriel Monteiro da Silva; Jordan Yang; Bunlong Leang; Jessie Huang; Daniel M Weinreich; Brenda M Rubenstein
Journal:  PLoS Comput Biol       Date:  2022-06-27       Impact factor: 4.779

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.